Do not use the information provided on this website for diagnosing or treating a health problem or disease, or prescribing medication or other treatment.
Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal, or other supplement, or using any treatment for a health problem.
If you have or suspect that you have a medical problem, contact your health care provider promptly.
Do not disregard professional medical advice or delay in seeking professional advice because of something you have read on this website.
Bellafill® is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years.
Patients who have had a positive reaction to the Bellafill® Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring should not receive Bellafill®.
The safety of Bellafill® for use during pregnancy, breastfeeding, or in patients under 21 has not been established.
You may experience temporary swelling, redness, pain, bruising, lumps/bumps, itching, and discoloration at the treatment site. These side effects are usually transient and typically resolve within 1–7 days. You may experience lumps/bumps/papules that may occur more than one month after injection and that may persist.
Less common side effects include rash and itching more than 48 hours after treatment, persistent swelling or redness, lumps/bumps, acne, and increased sensitivity at treatment sites. Infrequently, granulomas may occur and may be treated by your licensed physician provider. Be sure to call your licensed provider immediately if you notice any unusual skin reactions around the treatment area.
Based on the 5-year Post-Approval Study on nasolabial folds with 1,008 patients, long-term safety of Bellafill® for up to 5 years has been established.